Send feedback

MYO7B p.Ala1186Val

c.3557C>T · VCV4115740

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely benign
0.0818 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00933%, nfe)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt

Computational evidence

Protein change
AlphaMissense0.0818likely benign
REVEL0.152moderately benign-leaning
SaProtLLR -8.20tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI<0.2no splice effect predicted · four deltas, not one · how we know
Constraint at this position
ConservationphyloP 0.25GERP -1.8
Regional constrainto/e 0.94unconstrained · MANE · 69 kb · p 0.0075 · regional, not allelic
Overall
CADD8.062PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

⚠ Isoform check: AlphaMissense numbered on a different transcript (AM A1160V vs ClinVar A1186V) — verify the residue.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00933% European (non-Finnish) · 107/1,147,020 alleles
Filtering AF 0.00788% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00729%
Overall 0.00831% 129/1,551,698 alleles · very rare exomes 123/1,399,442 · genomes 6/152,256 · joint denominator
Ancestry group Frequency 1 in
Finnishnot grpmax-eligible 0.0234% 4,280
European (non-Finnish)grpmax 0.00933% 10,720
Remaining individualsnot grpmax-eligible 0.00832% 12,020
East Asian 0.00244% 40,942
Admixed American 0.00196% 50,992
African / African-American 0.00137% 73,072

Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
MYO7B
Protein
p.Ala1186Val
Coding
c.3557C>T
MANE Select
NM_001393586
Type
single nucleotide variant
Location
chr2:127622013 (GRCh38)
Gene constraint
LOEUF 0.956 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 78.34 · 3 PDB
Residue 1160 UniProt numbering
the 'mediates interaction with anks4b' region; the myth4 1 domain
Full MYO7B gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/myo7b-p-ala1186val (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown